Clinical Trial Update: A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy, safety and tolerability of Nexagon as a topical treatment for venous leg ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcers

Drugs mentioned

• NEXAGON

Snippet

Sponsor: OcuNexus Therapeutics, Inc. | Conditions: Venous Leg Ulcers | Phase 2 | Status: COMPLETED